Record FFO and Strong Free Cash Flow
Full-year 2025 adjusted FFO per share of $1.08 (company record) and free cash flow per share of $0.69, a 6% increase over 2024 and a 22% increase versus 2023.
Robust Full-Year EBITDA
Corporate adjusted EBITDA for full-year 2025 of $297.6 million and fourth-quarter corporate adjusted EBITDA of $71.9 million.
Outperformance from Renovations
Renovated assets drove meaningful gains: Kimpton Palomar Phoenix saw nearly 20% EBITDA improvement and a 15-point RevPAR index gain by December; L’Auberge integration produced ~15% RevPAR growth and >25% EBITDA growth post-renovation.
Out-of-Room Spend Resilience
Total out-of-room RevPAR increased 0.6% in Q4, outperforming RevPAR by ~90 bps; resort out-of-room revenue per occupied room rose nearly 7% (strongest quarterly growth of 2025).
Food & Beverage Strength and Margin Expansion
Food & beverage revenue rose 1.4% (banquets & catering up >2%, outlets up 0.5%) with F&B margins expanding 120 bps and food & beverage profits increasing over 5% despite modest revenue growth.
Expense Discipline and Margin Improvement
Total hotel operating expenses declined 0.5% in Q4, driving an 82 bps expansion in hotel EBITDA margin; wages & benefits increased just 0.6% in the quarter, reflecting productivity gains.
Simplified, Flexible Balance Sheet
Redeemed Series A preferred shares; no secured debt or off-balance-sheet encumbrances; three fully prepayable term loans; no debt maturities until 2029 (with extension options); 70% of debt floating (incl. swaps). Preferred redemption yields a $0.03 tailwind to 2026 FFO per share.
Capital Allocation and Shareholder Returns
Repurchased 4.8 million common shares in 2025 at an average $7.72/share; paid $0.80 quarterly common dividend (plus $0.04 Q4 stub) representing a 33% FFO payout; 2026 dividend guidance of $0.90 per quarter and continued focus on buybacks when attractive.
Measured Five-Year CapEx Plan
Announced CapEx program of 7%–9% of revenues (~$80M–$100M/year) vs. peer average 10%–11% — expected to redirect >$100M (cumulative) or ~$0.50 per share to higher-return uses over five years.
2026 Guidance with Modest Growth Expected
Guidance calls for 2026 RevPAR growth of 1%–3% (total RevPAR ~25 bps higher), adjusted EBITDA $287M–$302M, and midpoint-implied ~4% increase in free cash flow per share; 2026 CapEx expected $80M–$90M.